23andme Stock Symbol and Discounted Investment Opportunities

23andMe's stock symbol is LDNG, which is listed on the Nasdaq stock exchange.

The company went public in 2020, raising over $3.5 billion in its initial public offering.

As a publicly traded company, 23andMe's financial performance is now more transparent, making it easier for investors to make informed decisions about investing in the company.

Suggestion: Public Sq Stock Symbol

23andMe is a biotechnology company that offers direct-to-consumer genetic testing.

The company was founded in 2006 by Linda Avey, Paul Cusenza, and Anne Wojcicki.

23andMe has a strong focus on empowering individuals with their genetic information to take control of their health.

The company's headquarters is located in Mountain View, California.

23andMe has developed a number of innovative genetic testing products, including the Health + Ancestry test, which provides users with information about their genetic health risks, ancestry composition, and carrier status for certain genetic disorders.

In 2015, 23andMe received FDA clearance for its Personal Genome Service (PGS) for BRCA1 and BRCA2 genetic mutations, which are associated with an increased risk of breast and ovarian cancer.

See what others are reading: Cardinal Health Stock Symbol

Billionaires are buying discounted 23andMe stock, and it's worth taking a closer look. Several well-regarded funds run by famous billionaire investors bought shares of 23andMe during the last three months of 2023.

These investors are known for their savvy financial decisions, so it's natural to wonder if they're onto something. They're putting their money where their mouths are, and that's a good sign.

The fact that these funds are buying up 23andMe stock during a time when the company's shares are beaten down suggests they believe the stock has potential for growth.

For your interest: American Funds Stock Symbol